S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%

S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

KPTI

Karyopharm Therapeutics Inc. KPTI

$9.51 +0.13 (+1.39%)

Neutral · -0.26σ

+ Compare Open in Sniper

News · KPTI

Full news feed →

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

GlobeNewswire Inc. · 33d ago

International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month

GlobeNewswire Inc. · 503d ago

Glioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033

GlobeNewswire Inc. · 599d ago

Down -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics Looks Ripe for a Turnaround

Benzinga · 680d ago

Advanced Melanoma Clinical Trial Pipeline Analysis - GlobeNewswire

GlobeNewswire Inc. · 739d ago

Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript

The Motley Fool · 800d ago

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research · 869d ago

Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?

Zacks Investment Research · 879d ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research · 883d ago

Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know

Zacks Investment Research · 884d ago

5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their Money

Investing.com · 892d ago

The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

MarketWatch · 923d ago

6 Analysts Have This to Say About Karyopharm Therapeutics

Benzinga · 1079d ago

Penny Stocks To Buy Now? 3 With Ratings Up To 1,742%

PennyStocks · 1079d ago

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Benzinga · 1095d ago

All You Need to Know About Karyopharm Therapeutics (KPTI) Rating Upgrade to Buy

Zacks Investment Research · 1108d ago

Why Karyopharm Therapeutics Shares Slumped Thursday

The Motley Fool · 1170d ago

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga · 1170d ago

Revolution Medicines, Inc. (RVMD) Expected to Beat Earnings Estimates: Should You Buy?

Zacks Investment Research · 1173d ago

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday

Benzinga · 1186d ago

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday

Benzinga · 1191d ago